What is off-label prescribing?
Off-label prescribing occurs when a licensed physician prescribes an FDA-approved medication for a condition, dose, age group, or route of administration not included in the drug's official labeling.
When a doctor writes a prescription for an FDA-approved medication to treat a condition other than those listed on the drug's official label, that is off-label prescribing. The drug itself has cleared FDA review and is legal to distribute, but the specific use falls outside the approved indications.
In testosterone replacement therapy, off-label prescribing is common. FDA-approved testosterone products carry labels for treating hypogonadism stemming from disease or injury of the testicles, pituitary gland, or hypothalamus. However, physicians may prescribe testosterone off-label for age-related low testosterone, sexual dysfunction linked to testosterone deficiency, or fatigue without an underlying medical diagnosis. Some clinics also use testosterone at doses or frequencies not specified in approved labeling, or combine it with other compounds for symptom management.
This practice is legal under U.S. law and occurs frequently in medicine. Doctors can prescribe any approved drug for any condition based on clinical judgment, medical literature, and patient need. However, it carries distinct implications: off-label uses typically lack the same regulatory oversight, clinical trial data, and insurance coverage as approved indications. Patients should understand what their prescriber is doing and why. Those seeking TRT from licensed providers should ask whether their treatment plan follows approved labeling or involves off-label use. Hormone therapy clinics in Florida vary in their approach to these distinctions.